{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:15:43Z","timestamp":1792664143246,"version":"4.5.0"},"reference-count":225,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.yexcr.2014.04.021","type":"journal-article","created":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T20:31:47Z","timestamp":1399235507000},"page":"111-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Oral epithelial stem cells\u2014Implications in normal development and cancer metastasis"],"prefix":"10.1016","volume":"325","author":[{"given":"Silvana","family":"Papagerakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"About","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar","family":"Taqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghia P.T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarite","family":"Matossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"McAlpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Papagerakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2014.04.021_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ceb.2013.01.009","article-title":"Control of the epithelial stem cell epigenome: the shaping of epithelial stem cell identity","volume":"25","author":"Iglesias-Bartolome","year":"2013","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.oraloncology.2013.06.010","article-title":"Relevance of cancer initiating\/stem cells in carcinogenesis and therapy resistance in oral cancer","volume":"49","author":"Sinha","year":"2013","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0738-081X(00)00140-1","article-title":"Oral mucosal embryology and histology","volume":"18","author":"Winning","year":"2000","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib4","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/dvdy.23804","article-title":"Lineage tracing of the endoderm during oral development","volume":"241","author":"Rothova","year":"2012","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.yexcr.2014.04.021_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ijos.2013.46","article-title":"Oral epithelial stem cells in tissue maintenance and disease: the first steps in a long journey","volume":"5","author":"Jones","year":"2013","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.yexcr.2014.04.021_bib6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1177\/00220345870660080201","article-title":"The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa","volume":"66","author":"Collins","year":"1987","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc3184","article-title":"Cancer stem cells: an evolving concept","volume":"12","author":"Nguyen","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib8","first-page":"146","article-title":"The stem cell code in oral epithelial tumorigenesis: the cancer stem cell shift hypothesis","volume":"1806","author":"Richard","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2014.04.021_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jop.12073","article-title":"Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma","author":"Abdulmajeed","year":"2013","journal-title":"J. Oral Pathol. Med. Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology"},{"key":"10.1016\/j.yexcr.2014.04.021_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.jncimonographs.a003443","article-title":"Biology of oral mucosa and esophagus","author":"Squier","year":"2001","journal-title":"J. Nat. Cancer Inst. Monogr."},{"key":"10.1016\/j.yexcr.2014.04.021_bib11","series-title":"Human Oral Mucosa: Development, Structure and Function","author":"Squier","year":"1976"},{"key":"10.1016\/j.yexcr.2014.04.021_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000342926","article-title":"Morphogenesis of rete ridges in human oral mucosa: a pioneering morphological and immunohistochemical study","volume":"197","author":"Wu","year":"2013","journal-title":"Cell Tissues Organs"},{"key":"10.1016\/j.yexcr.2014.04.021_bib13","unstructured":"R. Lanza, Essential of Stem Cell Bilogy. second ed. In: (Eds.) R. Lanza, J. Gearhart, B. Hogan, D. Melton, R. Pedersen, E.D. Thomas, J. Thomson, Sir I. Wilmut, Elsevier Inc. Academic Press, isbn: 978-0-12-374729-7."},{"key":"10.1016\/j.yexcr.2014.04.021_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.stem.2007.09.014","article-title":"Sic transit gloria: farewell to the epidermal transit amplifying cells?","volume":"1","author":"Jones","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2014.04.021_bib15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1158\/0008-5472.CAN-11-3070","article-title":"Cancer stem cells: distinct entities or dynamically regulated phenotypes?","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9440(10)65306-0","article-title":"Circadian variation in the expression of cell-cycle proteins in human oral epithelium","volume":"154","author":"Bjarnason","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/bjom.1999.0130","article-title":"Mapping dynamic epithelial cell proliferative activity within the oral cavity of man: a new insight into carcinogenesis?","volume":"37","author":"Thomson","year":"1999","journal-title":"Br. J. Oral Maxillofacial Surg."},{"key":"10.1016\/j.yexcr.2014.04.021_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1242\/jcs.22.1.149","article-title":"The ordered columnar structure of mouse filiform papillae","volume":"22","author":"Hume","year":"1976","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2014.04.021_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2230.1983.tb01749.x","article-title":"Proliferative units in startified squamous epithelium","volume":"8","author":"Hume","year":"1983","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0003-9969(89)90104-0","article-title":"A topographical study of the circadian rhythm in labelling index of mouse gingival and floor-of-mouth epithelium, including changes in labelling activity with individual cell position on the epithelial ridges","volume":"34","author":"Kellett","year":"1989","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature10649","article-title":"The circadian molecular clock creates epidermal stem cell heterogeneity","volume":"480","author":"Janich","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.04.021_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.gep.2010.12.002","article-title":"Expression of clock proteins in developing tooth","volume":"11","author":"Zheng","year":"2011","journal-title":"Gene Expression Patterns: GEP"},{"key":"10.1016\/j.yexcr.2014.04.021_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s10266-013-0133-2","article-title":"Co-expression of CD44+\/RANKL+ tumor cells in the carcinogenesis of oral squamous cell carcinoma","author":"Grimm","year":"2013","journal-title":"Odontology"},{"key":"10.1016\/j.yexcr.2014.04.021_bib24","doi-asserted-by":"crossref","first-page":"e32459","DOI":"10.1371\/journal.pone.0032459","article-title":"EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells","volume":"7","author":"Abhold","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.04.021_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/002215540305100415","article-title":"The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma","volume":"51","author":"Du","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.yexcr.2014.04.021_bib26","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1038\/sj.onc.1206758","article-title":"Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents","volume":"22","author":"Nickoloff","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.04.021_bib27","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1207947","article-title":"Self-renewal and solid tumor stem cells","volume":"23","author":"Al-Hajj","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.04.021_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature02962","article-title":"Hedgehog signalling in prostate regeneration, neoplasia and metastasis","volume":"431","author":"Karhadkar","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.04.021_bib29","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1158\/0008-5472.CAN-06-0100","article-title":"Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome","volume":"66","author":"Dolled-Filhart","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"signalling and its impact on development and cancer","volume":"8","author":"Klaus","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/stem.690","article-title":"Concise review: stem cell effects in radiation risk","volume":"29","author":"Prise","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.yexcr.2014.04.021_bib32","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1158\/0008-5472.CAN-06-1073","article-title":"Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma","volume":"66","author":"Carvalho","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bjc.6604478","article-title":"Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas","volume":"99","author":"Tan","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-11-2392","article-title":"Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer","volume":"18","author":"Sun","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib35","doi-asserted-by":"crossref","first-page":"e54742","DOI":"10.1371\/journal.pone.0054742","article-title":"Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics","volume":"8","author":"Colacino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.04.021_bib36","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.04.021_bib37","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.04.021_bib38","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4161\/epi.6.6.16216","article-title":"Genome-wide methylation and expression differences in HPV(+) and HPV(\u2212) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis","volume":"6","author":"Sartor","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.yexcr.2014.04.021_bib39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4161\/epi.21038","article-title":"Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas","volume":"7","author":"Colacino","year":"2012","journal-title":"Epigenetics"},{"key":"10.1016\/j.yexcr.2014.04.021_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1008911300100","article-title":"Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States)","volume":"10","author":"Arbes","year":"1999","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.yexcr.2014.04.021_bib41","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2014.04.021_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1207\/S15430154JCE1801_15","article-title":"Oral cancer examinations among U.S. Hispanics in 1998","volume":"18","author":"Canto","year":"2003","journal-title":"J. Cancer Educ."},{"key":"10.1016\/j.yexcr.2014.04.021_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1752-7325.1998.tb03010.x","article-title":"Maryland adults\u2019 knowledge of oral cancer and having oral cancer examinations","volume":"58","author":"Horowitz","year":"1998","journal-title":"J. Public Health Dent."},{"key":"10.1016\/j.yexcr.2014.04.021_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hed.22973","article-title":"Head and neck squamous cell carcinoma in pregnant women","volume":"35","author":"Eliassen","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.yexcr.2014.04.021_bib45","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.14219\/jada.archive.2002.0330","article-title":"Oral cancer knowledge, risk factors and characteristics of subjects in a large oral cancer screening program","volume":"133","author":"Cruz","year":"2002","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.yexcr.2014.04.021_bib46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1055-9965.EPI-08-0347","article-title":"Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium","volume":"18","author":"Hashibe","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.yexcr.2014.04.021_bib47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10552-011-9892-7","article-title":"Oral microbiome and oral and gastrointestinal cancer risk","volume":"23","author":"Ahn","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.yexcr.2014.04.021_bib48","series-title":"Infections Causing Human Cancer","author":"Hausen","year":"2006"},{"key":"10.1016\/j.yexcr.2014.04.021_bib49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-9378-6-4","article-title":"The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview","volume":"6","author":"Pannone","year":"2011","journal-title":"Infect. Agent Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib50","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.hoc.2008.08.006","article-title":"Human papillomavirus in HNSCC: recognition of a distinct disease type","volume":"22","author":"Vidal","year":"2008","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.yexcr.2014.04.021_bib51","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/lary.21899","article-title":"Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970","volume":"122","author":"Chenevert","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.yexcr.2014.04.021_bib52","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/jnci\/djm233","article-title":"Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer","volume":"99","author":"Applebaum","year":"2007","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.yexcr.2014.04.021_bib53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.yexcr.2014.04.021_bib54","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1080\/01635581.2011.570894","article-title":"Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysis","volume":"63","author":"Arthur","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/lary.22133","article-title":"Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer","volume":"122","author":"Wansom","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.yexcr.2014.04.021_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.yexcr.2014.04.021_bib57","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1158\/1078-0432.CCR-09-2350","article-title":"Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence","volume":"16","author":"Maxwell","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib58","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1200\/JCO.2007.12.7597","article-title":"Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number","volume":"26","author":"Worden","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib59","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.2007.12.7662","article-title":"EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer","volume":"26","author":"Kumar","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib60","series-title":"Oral Cancer","author":"Shah","year":"2003"},{"key":"10.1016\/j.yexcr.2014.04.021_bib61","series-title":"Oral Cancer Metastasis","author":"Myers","year":"2010"},{"key":"10.1016\/j.yexcr.2014.04.021_bib62","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.oraloncology.2012.03.014","article-title":"Distant metastases from head and neck squamous cell carcinoma. Part II. Diagnosis","volume":"48","author":"de Bree","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib63","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archotol.132.7.762","article-title":"Risk factors for distant metastases in head and neck squamous cell carcinoma","volume":"132","author":"Garavello","year":"2006","journal-title":"Arch. Otolaryngol.\u2014Head Neck Surg."},{"key":"10.1016\/j.yexcr.2014.04.021_bib64","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.oraloncology.2005.11.012","article-title":"Higher distant failure in young age tongue cancer patients","volume":"42","author":"Liao","year":"2006","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.oraloncology.2012.03.019","article-title":"Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment","volume":"48","author":"Haigentz","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib66","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fendo.2012.00090","article-title":"The role of head and neck squamous cell carcinoma cancer stem cells in tumorigenesis, metastasis, and treatment failure","volume":"3","author":"Chinn","year":"2012","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib67","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yexmp.2009.04.003","article-title":"Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study","volume":"87","author":"Desai","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib68","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.critrevonc.2011.03.004","article-title":"Stem cells in squamous head and neck cancer","volume":"81","author":"Albers","year":"2012","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gde.2007.12.007","article-title":"Immune surveillance: a balance between protumor and antitumor immunity","volume":"18","author":"Ostrand-Rosenberg","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.yexcr.2014.04.021_bib70","doi-asserted-by":"crossref","first-page":"346345","DOI":"10.1155\/2009\/346345","article-title":"Immunotherapy of head and neck cancer: current and future considerations","volume":"2009","author":"Rapidis","year":"2009","journal-title":"J. Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib71","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.04.021_bib72","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1158\/1078-0432.CCR-12-1008","article-title":"Decreased NK cells in patients with head and neck cancer determined in archival DNA","volume":"18","author":"Accomando","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib73","doi-asserted-by":"crossref","first-page":"701657","DOI":"10.1155\/2010\/701657","article-title":"Immune suppression in head and neck cancers: a review","volume":"2010","author":"Duray","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib74","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-04-0054","article-title":"Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck","volume":"10","author":"Kuss","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib75","first-page":"161","article-title":"Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease","volume":"62","author":"Kuss","year":"2005","journal-title":"Adv. Otorhinolaryngol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib76","first-page":"3053","article-title":"Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages","volume":"29","author":"Wulff","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib77","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.04.021_bib78","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2014.04.021_bib80","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2014.04.021_bib81","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/ijc.22476","article-title":"CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity","volume":"120","author":"Yin","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib82","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1053\/j.gastro.2011.08.009","article-title":"c-Met is a marker of pancreatic cancer stem cells and therapeutic target","volume":"141","author":"Li","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2014.04.021_bib83","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-06-4180","article-title":"CD133(+) and CD133(\u2212) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles","volume":"67","author":"Beier","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib84","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1073\/pnas.0703478104","article-title":"Phenotypic characterization of human colorectal cancer stem cells","volume":"104","author":"Dalerba","year":"2007","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib85","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1541-7786.MCR-08-0035","article-title":"Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations","volume":"6","author":"Ma","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib86","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","article-title":"Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4","volume":"1","author":"Todaro","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2014.04.021_bib87","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/hep.22082","article-title":"Identification of local and circulating cancer stem cells in human liver cancer","volume":"47","author":"Yang","year":"2008","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.yexcr.2014.04.021_bib88","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","article-title":"Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis","volume":"69","author":"Huang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2009.05.048","article-title":"Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer","volume":"385","author":"Chen","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2014.04.021_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028246","article-title":"Granulin\u2013epithelin precursor is an oncofetal protein defining hepatic cancer stem cells","volume":"6","author":"Cheung","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.04.021_bib91","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1073\/pnas.0610117104","article-title":"Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma","volume":"104","author":"Prince","year":"2007","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib92","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hed.21315","article-title":"Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase","volume":"32","author":"Clay","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.yexcr.2014.04.021_bib93","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1158\/0008-5472.CAN-10-1712","article-title":"Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells","volume":"70","author":"Krishnamurthy","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib94","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0194599813482879","article-title":"In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells","volume":"149","author":"Czerwinski","year":"2013","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.yexcr.2014.04.021_bib95","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hed.23076","article-title":"Orosphere assay: a method for propagation of head and neck cancer stem cells","volume":"35","author":"Krishnamurthy","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.yexcr.2014.04.021_bib96","doi-asserted-by":"crossref","first-page":"24731","DOI":"10.1074\/jbc.M502573200","article-title":"Transcriptional regulation of nanog by OCT4 and SOX2","volume":"280","author":"Rodda","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2014.04.021_bib97","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/0008-5472.CAN-05-3850","article-title":"Exploring a new twist on tumor metastasis","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib98","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1158\/1078-0432.CCR-07-4404","article-title":"Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma","volume":"14","author":"Chiou","year":"2008","journal-title":"Clin. Cancer ResearchAn Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2014.04.021_bib99","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hed.20935","article-title":"In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line","volume":"31","author":"Wei","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.yexcr.2014.04.021_bib100","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1158\/1078-0432.CCR-09-0011","article-title":"Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma","volume":"15","author":"John","year":"2009","journal-title":"Clin. Cancer Research An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2014.04.021_bib101","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/ijc.25358","article-title":"Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma","volume":"127","author":"Vered","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/mp.52.4.189","article-title":"CD44 cell adhesion molecules","volume":"52","author":"Goodison","year":"1999","journal-title":"Mol.r Pathol.: MP"},{"key":"10.1016\/j.yexcr.2014.04.021_bib103","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.semcancer.2008.03.015","article-title":"Involvement of CD44, a molecule with a thousand faces, in cancer dissemination","volume":"18","author":"Naor","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib104","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/lary.20506","article-title":"CD44 variant isoforms in head and neck squamous cell carcinoma progression","volume":"119","author":"Wang","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.yexcr.2014.04.021_bib105","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-10-0799","article-title":"CD44 expression predicts local recurrence after radiotherapy in larynx cancer","volume":"16","author":"de Jong","year":"2010","journal-title":"Clin. Cancer Res. An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2014.04.021_bib106","first-page":"1920","article-title":"Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region","volume":"63","author":"Maula","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1758-3284-1-27","article-title":"Identification of potential therapeutic targets in human head & neck squamous cell carcinoma","volume":"1","author":"Han","year":"2009","journal-title":"Head Neck Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.oraloncology.2010.02.011","article-title":"Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer","volume":"46","author":"Lin","year":"2010","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib109","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.oraloncology.2011.03.026","article-title":"Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma","volume":"47","author":"Kokko","year":"2011","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1368-8375(99)00021-4","article-title":"Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas","volume":"35","author":"Stoll","year":"1999","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00001665-200201000-00020","article-title":"CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma","volume":"13","author":"Carinci","year":"2002","journal-title":"J. Craniofac Surg."},{"key":"10.1016\/j.yexcr.2014.04.021_bib112","first-page":"389","article-title":"Prognostic significance of p21WAF1\/CIP1, p16INK4a and CD44s in tongue cancer","volume":"18","author":"Gonzalez-Moles","year":"2007","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2014.04.021_bib113","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/00016489.2010.528792","article-title":"CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma","volume":"131","author":"Uwa","year":"2011","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib114","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V87.3.1097.bloodjournal8731097","article-title":"Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer","volume":"87","author":"Magni","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.04.021_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/scd.2008.0055","article-title":"ALDH1 as a functional marker of cancer stem and progenitor cells","volume":"18","author":"Douville","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.yexcr.2014.04.021_bib116","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/archoto.2010.219","article-title":"Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma","volume":"136","author":"Davis","year":"2010","journal-title":"Arch. Otolaryngol.\u2014Head Neck Surg."},{"key":"10.1016\/j.yexcr.2014.04.021_bib117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/039463201102400110","article-title":"Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma","volume":"24","author":"Pannone","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib118","first-page":"935","article-title":"Survivin promoter-31 G\/C polymorphism in oral cancer cell lines","volume":"2","author":"de Maria","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2014.04.021_bib119","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/039463201202500116","article-title":"Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer","volume":"25","author":"Papagerakis","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2013.06.007","article-title":"Clinico-pathologic relevance of Survivin splice variant expression in cancer","volume":"339","author":"Necochea-Campion","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2014.04.021_bib121","doi-asserted-by":"crossref","DOI":"10.1007\/s40291-013-0048-1","article-title":"Monitoring Survivin expression in cancer: implications for prognosis and therapy","author":"Guindalini","year":"2013","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.yexcr.2014.04.021_bib122","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1053\/j.gastro.2011.08.009","article-title":"c-Met is a marker of pancreatic cancer stem cells and therapeutic target","volume":"141","author":"Li","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2014.04.021_bib123","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/stem.690","article-title":"Concise review: stem cell effects in radiation risk","volume":"29","author":"Prise","year":"2011","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.yexcr.2014.04.021_bib124","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.oraloncology.2013.05.013","article-title":"Salivary gland cancer stem cells","volume":"49","author":"Adams","year":"2013","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial\u2013mesenchymal transition in cancer development and its clinical significance","volume":"101","author":"Iwatsuki","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2014.04.021_bib126","doi-asserted-by":"crossref","unstructured":"S. Papagerakis, G. Pannone, Epithelial\u2013mesenchymal interactions in oral cancer metastasis. In: K.U. Ogbureke (Ed.), Oral Cancer Tech. 2012, pp. 373\u2013388.","DOI":"10.5772\/32666"},{"key":"10.1016\/j.yexcr.2014.04.021_bib127","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2014.04.021_bib128","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0022034511423393","article-title":"Head and neck cancer stem cells","volume":"91","author":"Krishnamurthy","year":"2012","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib129","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-11-1059","article-title":"Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative","volume":"71","author":"Biddle","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib130","first-page":"e50561","article-title":"Generation of a novel dendritic-cell vaccine using melanoma and squamous cancer stem cells","volume":"83","author":"Li","year":"2014","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.yexcr.2014.04.021_bib131","first-page":"2905","article-title":"Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers","volume":"43","author":"Tsuruo","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib132","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-1-60761-416-6_15","article-title":"Overcoming multidrug resistance in cancer: clinical studies of P-glycoprotein inhibitors","volume":"596","author":"Coley","year":"2010","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"key":"10.1016\/j.yexcr.2014.04.021_bib133","first-page":"307","article-title":"Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells","volume":"37","author":"Zheng","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib134","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00280-009-0925-9","article-title":"A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen","volume":"64","author":"Ruff","year":"2009","journal-title":"Cancer Chemother. Pharmacolol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib135","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1200\/JCO.1998.16.11.3674","article-title":"Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance","volume":"16","author":"Bradshaw","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.yexcr.2014.04.021_bib136","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/annonc\/mdi396","article-title":"A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance","volume":"16","author":"Advani","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib137","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0889-8588(18)30099-6","article-title":"Clinical studies with modulators of multidrug resistance","volume":"9","author":"Fisher","year":"1995","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.yexcr.2014.04.021_bib138","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1158\/1078-0432.CCR-05-1945","article-title":"ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia","volume":"12","author":"Raaijmakers","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib139","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1124\/mol.65.5.1208","article-title":"Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport","volume":"65","author":"Zhang","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib140","doi-asserted-by":"crossref","first-page":"1676S","DOI":"10.3945\/ajcn.113.058271","article-title":"Cancer prevention by green tea: evidence from epidemiologic studies","volume":"98","author":"Yuan","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.yexcr.2014.04.021_bib141","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/mt.2011.105","article-title":"Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer","volume":"19","author":"Mamaeva","year":"2011","journal-title":"Mol. Ther. The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.yexcr.2014.04.021_bib142","first-page":"54","article-title":"IFN\u03b12b augments immune responses of cisplatin+5 fluorouracil treated tongue squamous cell carcinoma patients\u2014a preliminary study","volume":"136","author":"Mukherjee","year":"2012","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib143","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/156800912800673293","article-title":"Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinoma","volume":"12","author":"Liu","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.yexcr.2014.04.021_bib144","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4049\/jimmunol.159.2.990","article-title":"Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas","volume":"159","author":"Young","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib145","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1158\/1078-0432.CCR-10-1499","article-title":"Stem cell quiescence","volume":"17","author":"Ling","year":"2011","journal-title":"Clin. Cancer Res. An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2014.04.021_bib146","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jlb.65.5.623","article-title":"Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patients","volume":"65","author":"Lathers","year":"1999","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib147","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-014-0628-5","article-title":"The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled radiation therapy oncology group 9901 trial","author":"Hoffman","year":"2014","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib148","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/1078-0432.CCR-10-0196","article-title":"Nutting CM. Phase I\/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III\/IV squamous cell cancer of the head and neck","volume":"16","author":"Harrington","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib149","doi-asserted-by":"crossref","first-page":"e47287","DOI":"10.1371\/journal.pone.0047287","article-title":"Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer","volume":"7","author":"Gros","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.04.021_bib150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ejca.2010.09.028","article-title":"Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases","volume":"47","author":"Uchida","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib151","doi-asserted-by":"crossref","first-page":"31","DOI":"10.18632\/oncotarget.430","article-title":"A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer","volume":"3","author":"Stauber","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2014.04.021_bib152","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/cas.12271","article-title":"Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck","volume":"104","author":"Chikamatsu","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2014.04.021_bib153","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1158\/0008-5472.CAN-09-3028","article-title":"Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage","volume":"70","author":"Conti","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib154","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-12-3175","article-title":"Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment","volume":"19","author":"Connolly","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnci\/djj091","article-title":"Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients","volume":"98","author":"Khuri","year":"2006","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.yexcr.2014.04.021_bib156","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-8-76","article-title":"Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells","volume":"8","author":"Wei","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib157","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1073\/pnas.1120068109","article-title":"Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors","volume":"109","author":"Gurney","year":"2012","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib158","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1073\/pnas.1007428107","article-title":"Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies","volume":"107","author":"Ettenberg","year":"2010","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib159","doi-asserted-by":"crossref","first-page":"e12682","DOI":"10.1371\/journal.pone.0012682","article-title":"Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies","volume":"5","author":"Gong","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.04.021_bib160","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cellsig.2011.12.009","article-title":"Frizzled7 as an emerging target for cancer therapy","volume":"24","author":"King","year":"2012","journal-title":"Cell Signaling"},{"key":"10.1016\/j.yexcr.2014.04.021_bib161","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1073\/pnas.1323697111","article-title":"The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells","volume":"111","author":"Fernandez","year":"2014","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib162","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/0008-5472.SABCS12-P6-11-07","article-title":"Xu The cancer stem cell-targeting Wnt inhibitor VS-507 reduces breast cancer growth and metastasis","volume":"72","author":"Ring","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib163","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1039\/c1sc00203a","article-title":"An anti-cancer trinuclear ruthenium(iii) complex with 2-thiosalicylate ligands attenuates Wnt-\u0392-catenin signaling","volume":"2","author":"Chan","year":"2011","journal-title":"Chem. Sci."},{"key":"10.1016\/j.yexcr.2014.04.021_bib164","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bcp.2012.08.011","article-title":"The \u0392-catenin\/TCF complex as a novel target of resveratrol in the Wnt\/\u03b2-catenin signaling pathway","volume":"84","author":"Chen","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib165","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.taap.2013.07.019","article-title":"3,5,4\u2032-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K\/Akt and Wnt\/\u03b2-catenin signaling cascades and reversal of epithelial\u2013mesenchymal transition","volume":"272","author":"Tsai","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib166","first-page":"632121","article-title":"Resveratrol inhibits alpha-melanocyte-stimulating hormone signaling, viability, and invasiveness in melanoma cells","volume":"2013","author":"Chen","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.yexcr.2014.04.021_bib167","doi-asserted-by":"crossref","first-page":"590393","DOI":"10.1155\/2013\/590393","article-title":"ResveratrolImpedes the stemness, epithelial\u2013mesenchymal transition, and metabolic reprogramming of cancer stem cells in nasopharyngeal carcinoma through p53 activation","volume":"2013","author":"Shen","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.yexcr.2014.04.021_bib168","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1038\/onc.2012.519","article-title":"Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer","volume":"32","author":"Pandey","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.04.021_bib169","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/mi.8.4.9","article-title":"Targeting cancer stem cells with phytochemicals","volume":"8","author":"Kawasaki","year":"2008","journal-title":"Mol. Interventions"},{"key":"10.1016\/j.yexcr.2014.04.021_bib170","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/carcin\/bgs216","article-title":"Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research","volume":"33","author":"Singh","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2014.04.021_bib171","article-title":"Small-molecule inhibition of CBP\/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia","author":"Gang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2014.04.021_bib172","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/emboj.2013.127","article-title":"Wnt\/\u03b2-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours","volume":"32","author":"Wend","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2014.04.021_bib173","doi-asserted-by":"crossref","first-page":"e33976","DOI":"10.1371\/journal.pone.0033976","article-title":"Small molecule antagonists of the Wnt\/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2\/Neu mouse model of breast cancer","volume":"7","author":"Hallett","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.04.021_bib174","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nchembio.137","article-title":"Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer","volume":"5","author":"Chen","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib175","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1073\/pnas.1307218110","article-title":"Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma","volume":"110","author":"Jiang","year":"2013","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib176","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/0008-5472.CAN-12-2258","article-title":"Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer","volume":"73","author":"Proffitt","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib177","doi-asserted-by":"crossref","first-page":"20224","DOI":"10.1073\/pnas.1314239110","article-title":"Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.yexcr.2014.04.021_bib178","doi-asserted-by":"crossref","first-page":"748587","DOI":"10.1155\/2013\/748587","article-title":"Targeting sonic hedgehog signaling by compounds and derivatives from natural products","volume":"2013","author":"Huang","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.yexcr.2014.04.021_bib179","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1158\/0008-5472.CAN-12-4047","article-title":"Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer","volume":"73","author":"Keysar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib180","first-page":"943","article-title":"Gamma secretase inhibitors of Notch signaling","volume":"6","author":"Olsauskas-Kuprys","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.yexcr.2014.04.021_bib181","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/labinvest.2013.95","article-title":"The pathological significance of Notch1 in oral squamous cellcarcinoma","volume":"93","author":"Yoshida","year":"2013","journal-title":"Lab. Invest."},{"key":"10.1016\/j.yexcr.2014.04.021_bib182","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2011.02.034","article-title":"Suppression of the notch signaling pathway by \u03b3-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation","volume":"306","author":"Chen","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2014.04.021_bib183","first-page":"1323","article-title":"Down-regulation of Notch signalingby a \u03b3-secretase inhibitor enhances the radiosensitivity of nasopharyngeal carcinoma cells","volume":"26","author":"Yu","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2014.04.021_bib184","doi-asserted-by":"crossref","first-page":"e30590","DOI":"10.1371\/journal.pone.0030590","article-title":"Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling","volume":"7","author":"Subramaniam","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2014.04.021_bib185","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.bcp.2007.08.001","article-title":"Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells","volume":"74","author":"Cecchinato","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib186","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/bjc.2013.642","article-title":"Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells","volume":"109","author":"Suman","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib187","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/pr.111.005538","article-title":"Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application","volume":"64","author":"Koppaka","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.yexcr.2014.04.021_bib188","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10549-011-1692-y","article-title":"Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells","volume":"133","author":"Croker","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.yexcr.2014.04.021_bib189","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/bjc.2013.534","article-title":"Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells","volume":"109","author":"Liu","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biopha.2013.04.005","article-title":"The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance","volume":"67","author":"Januchowski","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2014.04.021_bib191","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.yexcr.2014.04.021_bib192","first-page":"85","article-title":"Systems analysis reveals a transcriptional reversal of the mesenchymal phenotype induced by SNAIL-inhibitor GN-25. BMC","volume":"7","author":"Azmi","year":"2013","journal-title":"Syst. Biol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib193","first-page":"249063","article-title":"The role of TGF\u03b2 signaling in squamous cell cancer: lessons from mouse models","author":"Glick","year":"2012","journal-title":"J. Skin Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib194","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1158\/0008-5472.CAN-07-0801","article-title":"Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11010-009-0267-2","article-title":"NF-kappaB and cancer: how intimate is this relationship","volume":"336","author":"Prasad","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2014.04.021_bib196","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/path.2826","article-title":"MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells","volume":"223","author":"Lo","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib197","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1158\/1940-6207.CAPR-11-0267","article-title":"Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer","volume":"4","author":"Saini","year":"2011","journal-title":"Cancer Prev. Res. (Philadelphia, PA)"},{"key":"10.1016\/j.yexcr.2014.04.021_bib198","first-page":"871","article-title":"Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck","volume":"3","author":"Merlano","year":"2007","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.yexcr.2014.04.021_bib199","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1470-2045(09)70002-6","article-title":"Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I\/II study","volume":"10","author":"Cohen","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib201","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/bjc.2011.237","article-title":"Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck","volume":"105","author":"Del Campo","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib202","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/1535-7163.MCT-12-0995","article-title":"BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer","volume":"12","author":"Kutluk Cenik","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.yexcr.2014.04.021_bib203","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1200\/JCO.2009.25.6834","article-title":"Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420","volume":"28","author":"Williamson","year":"2010","journal-title":"J. Clin. Oncol. Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.yexcr.2014.04.021_bib204","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","article-title":"GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition","volume":"17","author":"Gilmartin","year":"2011","journal-title":"Clin. Cancer Res. An Official Journal of the American Association for Cancer Research"},{"key":"10.1016\/j.yexcr.2014.04.021_bib205","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4161\/cbt.5.7.2874","article-title":"A Phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer","volume":"5","author":"Argiris","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2014.04.021_bib206","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1158\/0008-5472.CAN-07-0669","article-title":"A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity","volume":"68","author":"Garlich","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib207","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14728222.2011.541440","article-title":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy","volume":"15","author":"Freudlsperger","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.yexcr.2014.04.021_bib208","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1245\/s10434-013-3146-8","article-title":"Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer","volume":"21","author":"Cai","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","article-title":"mTOR inhibitors in cancer therapy","volume":"319","author":"Zaytseva","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2014.04.021_bib210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/bjc.2011.495","article-title":"Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma","volume":"106","author":"Erlich","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib211","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1476-4598-10-90","article-title":"Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K\/mTOR inhibitor, in combination with sorafenib","volume":"10","author":"Roulin","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib212","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1460-9568.2006.04628.x","article-title":"Role of L-type Ca2+ channels in neural stem\/progenitor cell differentiation","volume":"23","author":"D\u05f3Ascenzo","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.yexcr.2014.04.021_bib213","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1014965726663","article-title":"Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell death","volume":"72","author":"Zhang","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.yexcr.2014.04.021_bib214","first-page":"1915","article-title":"Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole","volume":"3","author":"Wu","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib215","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.4161\/cc.9.14.12371","article-title":"Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs","volume":"9","author":"Cioce","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexcr.2014.04.021_bib216","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1158\/1078-0432.CCR-07-4404","article-title":"Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma","volume":"14","author":"Chiou","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2014.04.021_bib217","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/lary.21032","article-title":"Head and neck cancer stem cells: the side population","volume":"12","author":"Tabor","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.yexcr.2014.04.021_bib218","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/hed.21576","article-title":"Bmi-1\u2019s maintenance of the proliferative capacity of laryngeal cancer stem cells","volume":"33","author":"Chen","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.yexcr.2014.04.021_bib219","doi-asserted-by":"crossref","DOI":"10.1111\/jop.12159","article-title":"Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis","author":"Huang","year":"2014","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.yexcr.2014.04.021_bib220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.oraloncology.2007.01.008","article-title":"EpCam expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features","volume":"44","author":"Laimer","year":"2008","journal-title":"Oral Oncol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib221","first-page":"28","article-title":"The xpresion profile of Oct4 and Sox 2 in the carcinogenesis of oral mucosa","volume":"7","author":"Qiao","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib222","first-page":"1471","article-title":"Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma","volume":"11","author":"Han","year":"2014","journal-title":"BioMed. Central Cancer"},{"key":"10.1016\/j.yexcr.2014.04.021_bib223","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/stem.425","article-title":"The lamina propria of adult human oral mucosa harbors a novel stem cell population","volume":"28","author":"Marynka-kalmani","year":"2010","journal-title":"Stem Cell"},{"key":"10.1016\/j.yexcr.2014.04.021_bib224","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/path.1822","article-title":"Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium","volume":"207","author":"Sheu","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.yexcr.2014.04.021_bib225","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-11-1059","article-title":"Cancer stem cells in squamous carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative","volume":"71","author":"Biddle","year":"2011","journal-title":"Cancer Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714001797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482714001797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:48:42Z","timestamp":1689166122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482714001797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":225,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0014482714001797"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.04.021","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral epithelial stem cells\u2014Implications in normal development and cancer metastasis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}